Encompass Health Corporation (EHC): Price and Financial Metrics
EHC Price/Volume Stats
Current price | $75.99 | 52-week high | $78.11 |
Prev. close | $74.75 | 52-week low | $51.30 |
Day low | $74.45 | Volume | 832,900 |
Day high | $76.46 | Avg. volume | 622,132 |
50-day MA | $72.91 | Dividend yield | 0.8% |
200-day MA | $68.08 | Market Cap | 7.61B |
EHC Stock Price Chart Interactive Chart >
EHC POWR Grades
- Sentiment is the dimension where EHC ranks best; there it ranks ahead of 92.76% of US stocks.
- EHC's strongest trending metric is Growth; it's been moving down over the last 26 weeks.
- EHC's current lowest rank is in the Momentum metric (where it is better than 26.24% of US stocks).
EHC Stock Summary
- EHC's went public 34.33 years ago, making it older than 88.85% of listed US stocks we're tracking.
- The ratio of debt to operating expenses for ENCOMPASS HEALTH CORP is higher than it is for about 86.02% of US stocks.
- In terms of volatility of its share price, EHC is more volatile than merely 4.22% of stocks we're observing.
- Stocks that are quantitatively similar to EHC, based on their financial statements, market capitalization, and price volatility, are ARMK, SKT, AROC, DO, and PANL.
- Visit EHC's SEC page to see the company's official filings. To visit the company's web site, go to www.encompasshealth.com.
EHC Valuation Summary
- In comparison to the median Healthcare stock, EHC's price/sales ratio is 36.36% lower, now standing at 1.4.
- Over the past 243 months, EHC's price/sales ratio has gone up 1.
Below are key valuation metrics over time for EHC.
Stock | Date | P/S | P/B | P/E | EV/EBIT |
---|---|---|---|---|---|
EHC | 2023-12-29 | 1.4 | 4.3 | 14.5 | 12.9 |
EHC | 2023-12-28 | 1.4 | 4.3 | 14.6 | 13.0 |
EHC | 2023-12-27 | 1.4 | 4.3 | 14.7 | 13.0 |
EHC | 2023-12-26 | 1.4 | 4.3 | 14.7 | 13.0 |
EHC | 2023-12-22 | 1.4 | 4.3 | 14.6 | 13.0 |
EHC | 2023-12-21 | 1.4 | 4.3 | 14.5 | 12.9 |
EHC Growth Metrics
- The year over year net income to common stockholders growth rate now stands at 25.86%.
- The 3 year net cashflow from operations growth rate now stands at 9.94%.
- Its 5 year net cashflow from operations growth rate is now at -19.45%.
The table below shows EHC's growth in key financial areas (numbers in millions of US dollars).
Date | Revenue | Operating Cash Flow | Net Income to Common Stock |
---|---|---|---|
2022-12-31 | 4,348.6 | 705.8 | 365.9 |
2022-09-30 | 5,072.3 | 657.4 | 364.1 |
2022-06-30 | 5,267.6 | 764.9 | 423.8 |
2022-03-31 | 5,224.8 | 776.2 | 494.5 |
2021-12-31 | 5,121.6 | 715.8 | 517.2 |
2021-09-30 | 5,017.3 | 871.7 | 513.2 |
EHC's Quality Factors
The “Quality” component of the POWR Ratings focuses on 31 different factors of a companies fundamentals and operational strength. Here are some key insights as we drill into the specifics of these quality attributes.- EHC has a Quality Grade of C, ranking ahead of 64.25% of graded US stocks.
- EHC's asset turnover comes in at 0.749 -- ranking 39th of 81 Healthcare stocks.
- USPH, AMED, and NTRA are the stocks whose asset turnover ratios are most correlated with EHC.
The table below shows EHC's key quality metrics over time.
Period | Asset Turnover | Gross Margin | ROIC |
---|---|---|---|
2021-06-30 | 0.749 | 1 | 0.128 |
2021-03-31 | 0.719 | 1 | 0.108 |
2020-12-31 | 0.723 | 1 | 0.103 |
2020-09-30 | 0.729 | 1 | 0.086 |
2020-06-30 | 0.733 | 1 | 0.092 |
2020-03-31 | 0.764 | 1 | 0.108 |
EHC Price Target
For more insight on analysts targets of EHC, see our EHC price target page. And for a list of of all stocks sorted by upside potential based on analyst target price, see our Top Price Target page.
Average Price Target | $101.09 | Average Broker Recommendation | 1.31 (Strong Buy) |
Encompass Health Corporation (EHC) Company Bio
Encompass Health Corporation, formerly Healthsouth, owns and operates inpatient rehabilitation hospitals in the United States. The company provides specialized rehabilitative treatment on an inpatient and outpatient basis. The company was founded in 1983 and is based in Birmingham, Alabama.
Latest EHC News From Around the Web
Below are the latest news stories about ENCOMPASS HEALTH CORP that investors may wish to consider to help them evaluate EHC as an investment opportunity.
Brookdale (BKD) Concludes Transactions to Extend Debt RepaymentBrookdale (BKD) completes two financing transactions to push its debt maturities until September 2025, thereby relieving it from the debt repayment burden for next year and focusing on core operations. |
Why You Should Invest in Encompass Health (EHC) Stock for NowEncompass Health (EHC) is well-poised for growth on the back of growing revenues, an aging U.S. population, joint ventures and solid cash reserves. |
5 Investing Tenets of Fidelity Veteran Joel TillinghastThe manager of the winning Fidelity Low-Priced Stock fund favors quality companies whose valuations afford a margin of safety. |
Encompass Health (EHC) is a Top-Ranked Value Stock: Should You Buy?Whether you're a value, growth, or momentum investor, finding strong stocks becomes easier with the Zacks Style Scores, a top feature of the Zacks Premium research service. |
Why Encompass Health (EHC) is a Top Momentum Stock for the Long-TermWondering how to pick strong, market-beating stocks for your investment portfolio? Look no further than the Zacks Style Scores. |
EHC Price Returns
1-mo | 3.32% |
3-mo | 14.15% |
6-mo | 9.17% |
1-year | 48.82% |
3-year | -1.87% |
5-year | 36.51% |
YTD | 13.89% |
2023 | 12.62% |
2022 | -6.92% |
2021 | -19.90% |
2020 | 21.42% |
2019 | 14.26% |
EHC Dividends
Ex-Dividend Date | Type | Payout Amount | Change | ||||||
---|---|---|---|---|---|---|---|---|---|
Loading, please wait... |
Continue Researching EHC
Here are a few links from around the web to help you further your research on Encompass Health Corp's stock as an investment opportunity:Encompass Health Corp (EHC) Stock Price | Nasdaq
Encompass Health Corp (EHC) Stock Quote, History and News - Yahoo Finance
Encompass Health Corp (EHC) Stock Price and Basic Information | MarketWatch
Loading social stream, please wait...